Dr. Soon-Shiong joins Nobel laureates, former NIH directors, and leading oncology pioneers in Washington, D.C. to chart a path toward defeating cancer by 2035, with the discussion streamed live at ...

A lung cancer trial bolsters a long-held idea that treatment timing matters, showing a simple shift could help immunotherapy ...

A new Research Triangle company, Persistence Therapeutics, is developing a small, implantable device that generates and delivers genetically engineered T cells directly inside the body. These cells, ...

Nature Medicine starts an investigation into inconsistencies in a study that found it was better to have immunotherapy in the ...

Scientists at McGill University and the Rosalind and Morris Goodman Cancer Institute have developed a new way to deliver ...

Rare tumors, although individually uncommon, collectively account for a considerable proportion of cancer diagnoses and pose unique clinical and biological ...

Immunotherapy given before or after surgery is increasingly used across several cancer areas. In an article published in the ...

Researchers say study results provide a clear rationale for developing therapies that target LCN2 in lung cancer patients.

Mayo Clinic researchers and collaborators have identified a previously unrecognized way lung tumors weaken the immune system, ...